Find a TenderPast planning notice
Published 7 Jun 2021, 12:15 BST

Official UK procurement notice

Provision of Sequencing Panel for Detection of Gene Fusions In Cancer

Official notice

Authority: NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) (Central government)

Goods
Planned pipeline valueValue not publishedpipeline notice, not a live tender
Tender notice expected 1 Oct 2021from the planned procurement notice

What is being bought

Published requirement description

The All Wales Genomics Laboratory intends to procure an RNA sequencing panel to enable the identification of gene fusion events in somatic tissue samples, to replace the current laboratory tests.

AWGL currently offers a range of gene fusion detection services using predominantly fluorescence in situ hybridisation (FISH) together with a limited number of qPCR assays. These tests cover the common genetic translocations seen in haematological malignancies, lymphomas, sarcomas and solid tumour referrals in a range of tissues including bone marrow, peripheral blood and formalin-fixed paraffin embedded (FFPE) tissues.

CPV: Laboratory reagents

The lotProcurement structure

single lot · no lot value published
Lot #1The All Wales Genomics Laboratory intends to procure an RNA sequencing panel to enable…Planned

The All Wales Genomics Laboratory intends to procure an RNA sequencing panel to enable the identification of gene fusion events in somatic tissue samples.

AWGL currently offers a range of gene fusion detection services using predominantly fluorescence in situ hybridisation (FISH) together with a limited number of qPCR assays. These tests cover the common genetic translocations seen in haematological malignancies, lymphomas, sarcomas and solid tumour referrals in a range of tissues including bone marrow, peripheral blood and formalin-fixed paraffin embedded (FFPE) tissues.

In 2020/21 the laboratory received referrals from over 3000 samples for gene fusion translocation testing. Many of these samples were interrogated for more than 1 gene fusion event.

The laboratory intends to introduce and NGS assay that will ensure the following objectives are met-

  • Workflow Standardisation - Introduction of a single NGS assay that can be used to detect a variety of clinically relevant gene fusions, across a range of sample types and cancers.
  • Streamlining Analysis – NGS assay allows the transfer of fusion analysis from predominantly microscopy based analyses (FISH) to a more sensitive and standardised method.
  • Service Improvement – Allows reduction of turnaround times by simultaneous detection of all clinically relevant gene fusion events using a protocol that is amenable to automation.
  • Expansion of gene fusion testing repertoire - Flexibility in panel content for future proofing against new testing requirements in cancer.

We anticipate that an invitation to tender will be published in autumn 2021, with a view to begin service delivery in spring 2022.

AWGL invite suppliers to present their solution via Teams/Skype/Zoom on a mutually convenient time/date between Monday 5th July and Friday 16th July 2021.

The presentation should detail how your solution may best meet our needs with time for questions at the end.

Please contact Ryan James, [email protected] to arrange a meeting, where you will be provided a list of information that the laboratory requests you cover in your presentation.

Delivery: Wales · All Wales Genomics Laboratory Institute of Medical Genetics University Hospital of Wales Heath Park Cardiff CF14 4XW

Procedure terms & legal framework

From the official record · publisher note attached
Legal basis
CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
Procurement category
Goods
Notice status
Past planning notice
Procurement threshold
Unspecified in notice
Regulatory regime
Standard
Commercial structure
Stand-alone contract (no framework)
Competition type
Competitive procedure
GPA / WTO covered
Yes (GPA)
Recurring procurement
Unspecified in notice
First published
7 Jun 2021, 12:15 BST
Last source update
7 Jun 2021, 12:15 BST
FTS notice number
2021/S 000-012659
Classification (CPV)
Laboratory reagents
Delivery area
Wales (UKL22)
Official registry OCID
ocds-h6vhtk-02b8e4 Find a Tender

Publisher note: NOTE: To register your interest in this notice and obtain any additional information please visit the Sell2Wales Web Site at https://www.sell2wales.gov.wales/Search/Search_Switch.aspx?ID=111195. (WA Ref:111195)

How it was run

Official notice
Submission deadline
—

Timeline

7 Jun 2021 → 1 Oct 2021 · 2 dates
  1. Notice published
    7 Jun 2021, 12:15 BST
  2. Tender notice expected
    1 Oct 2021, 00:00 BST

Commercial outcome & contract awards

Pipeline notice
Awards (0)
No award published
Contracts (0)
No contract published
Bid statistics
No aggregate bid statistics published

Contracting authority & participating public bodies

NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)

Contracting authorityCentral GovernmentBody governed by public lawHealth 4-5 Charnwood Court,, Heol Billingsley, Parc Nantgarw, Cardiff, UK, CF15 7QZContact name, email, phone

Official documents & specifications

Official links; attachments are not copied

No document links were published on the notice.